Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: AJR Am J Roentgenol. 2012 Aug;199(2):278–291. doi: 10.2214/AJR.12.8816

Fig. 3.

Fig. 3

Sagittal fused PET/CT and PET images of 16β-[18F]fluoro-5α-dihydrotestosterone (FDHT) (top) and FDG (bottom) uptake in two different patients with castrate-resistant metastatic prostate cancer.

A, Glycolysis–androgen receptor concordant phenotype.

B, Androgen receptor predominant phenotype. (Reprinted with permission from [47])